Saturday July 4 2009 | Biotechnology feed | All feeds
|
|
Ebixa
Download detailed PDF Members: Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in the brain.
This page has been viewed 279 times since April 2007, the link to the organisation's website has been followed 64 times Recent Search Terms used to find this page: MOA ebixA | ebixa drug mechanism of action | ebixa UK 2008 | www.ebixa | ebixa | ebixa | ebixa.com | . Search for more companies in Copenhagen Search for more companies in Valby This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Ebixa | |||||||||||||||||||||||||||||||||||||||||||||||||||
|